Dow Jones received a payment from EQS/DGAP to publish this press release.
EQS-News / 30/01/2018 / 10:05 UTC+8
?*For Immediate Release*?
????????????
*China Shineway Pharmaceutical Group Limited *(*Stock Code: 2877*)
*Shineway's anti-flu medications
are in hot demand and short supply*
(Hong Kong, 31 January 2018) ---- The largest Chinese medicine injections,
soft capsules and granules manufacturer in PRC, *China Shineway
Pharmaceutical Group Limited*, and collectively with its subsidiaries
("China Shineway") (SEHK stock code: 2877) today told investors in a monthly
newsflash the following:
1. Since early January, the high rates of influenza in China has led to a
sharp increase in the demand for Shineway's anti-flu related medications,
subsequently causing shortage in their supply. Shineway's Qingkailing
Injection, Qingkailing Soft Capsule, Pediatric Qingfei Huatan Granule, Liyan
Jiedu Granule, Cold and Heat Removal Granules, and other anti-flu related
products have been constantly out of stock. Shineway's has been continuously
bolstering its production in response to the backorders situation in the
market.
2. "Research on the Quality of TCM Formula Granules " a book co-authored by
Shineway Pharmaceutical Group and Hebei College of Traditional Chinese
Medicine, has been officially published by the Science Press. The book has
received tremendous support and guidance from the Hebei Provincial Science &
Technology Agency, the Hebei Department of Education, the Hebei Provincial
TCM Administration, the Shijiazhuang Science and Technology Agency, and the
Intellectual Property Office. Inside, the book examines each of the 101
commonly clinical-use TCM formula granules using modern analytical
technology with reference to their quality standards, to establish a set of
methodology for assessing and analysing TCM formula granules to be used as
guidance for their quality controls. As there are currently no unified
technical requirements and quality standards for TCM formula granules in
China, this book is of great significance to the research on quality
standards and clinical applications of TCM formula granules.
End
*About China Shineway Pharmaceutical Group Limited (Stock Code: 2877)*
China Shineway Pharmaceutical Group Limited is one of the largest modern
Chinese medicines manufacturers in the PRC. The Group is listed on the Main
Board of Hong Kong Stock Exchange and is also a Hang Seng Composite Index
constituent.
Media Contact:
China Shineway Pharmaceutical Group Limited
Mr. Randy Hung ¦ Tel: (852) 3521-0816 ¦ randyhung@shineway.com.hk
Document: http://n.eqs.com/c/fncls.ssp?u=HXVTAGQNBL [1]
Document title: Shineway's anti-flu medications are in hot demand and short
supply
30/01/2018 Dissemination of a Marketing Press Release, transmitted by EQS
Group.
The issuer is solely responsible for the content of this announcement.
Media archive at www.todayir.com
1: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=6d9bc33cd017d66aa2849ba1b0902031&application_id=649439&site_id=vwd&application_name=news
(END) Dow Jones Newswires
January 29, 2018 21:05 ET (02:05 GMT)
© 2018 Dow Jones News
